InvestorsHub Logo
icon url

shadolane

10/28/22 9:09 AM

#392014 RE: ralphey #392010

While I may agree with your statement if our fortunes are geared to success in the courts we are in a precarious spot. To date the courts have stomped on AMRN so I'm not sure we should have much hope in that arena.

But maybe that's our only hope as you said.

I and many others I'm sure would love to escape this nightmare.
icon url

rosemountbomber

10/28/22 10:17 AM

#392016 RE: ralphey #392010

And when is that case supposed to have a final decision?
icon url

Birdbrain Ideas

10/28/22 10:18 AM

#392018 RE: ralphey #392010

I am a dreamer, but I'm not the only one. RIP John Lennon. But seriously, a mere strong rumor that a sale of the company is in the works and AMRN is trading over $10 in two days, maybe less.

I don't see that happening for a year or two, but I see it happening. By then, we'll be over $5 a share. Once the prices are set in all the big European countries and we get a sense of how quickly sales can become meaningful in places like England, Italy and France and we know when the combination pill will be introduced, it'll be easier for a buyer to put a fair price on the company and it can be sold.

Then it'll sell between $20 and $26 a share, with the hammer price likely being closer to $26 than below.